Skip to main
IVVD

Invivyd Inc (IVVD) Stock Forecast & Price Target

Invivyd Inc (IVVD) Analyst Ratings

Based on 4 analyst ratings
Strong Buy
Strong Buy 75%
Buy 25%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Invivyd is well positioned to thrive in the biopharmaceutical industry with their successful development of PEMGARDA and their promising pipeline of antibody candidates for various viral diseases. They have a clear goal of improving quality of life for patients and a diverse portfolio that mitigates risks. Furthermore, their partnerships and focus on new variants showcase their ability to adapt to changing market conditions and remain competitive. While there are risks in the industry, Invivyd's track record and potential for future growth make it a strong investment opportunity with positive long-term prospects.

Bears say

Invivyd is heavily dependent on the success of its lead product PEMGARDA, approved for the prevention of COVID-19 in immunocompromised individuals. However, the next-generation antibody VYD2311 in its pipeline is not significantly different from PEMGARDA and may face stiff competition in the already crowded COVID-19 prophylaxis market. Additionally, the company's commercialization and regulatory risks should not be overlooked, as a large marketing partner may be needed for commercial success and the FDA's acceptance of immuno-bridging data for approval may not be guaranteed. The company's flu program shows potential but is not a significant contributor to its current valuation, leaving most of the stock's upside dependent on the success of its COVID-19 antibodies.

Invivyd Inc (IVVD) has been analyzed by 4 analysts, with a consensus rating of Strong Buy. 75% of analysts recommend a Strong Buy, 25% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Invivyd Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Invivyd Inc (IVVD) Forecast

Analysts have given Invivyd Inc (IVVD) a Strong Buy based on their latest research and market trends.

According to 4 analysts, Invivyd Inc (IVVD) has a Strong Buy consensus rating as of Jun 3, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $8, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $8, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Invivyd Inc (IVVD)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.